High-Frequency Microfluidic Fractionation for Compound-Resolved Bioactivity-Based Metabolomics
Analytical Chemistry · 04.11.2025 · 97 (43) · 24093-24104
DOI: 10.1021/acs.analchem.5c04612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 25.10.2025. Verfasst von Christian Geibel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), University of Tübingen, 72076 Tübi…. Hauptthemen laut MEDLINE: Metabolomics, Microfluidic Analytical Techniques, Lab-On-A-Chip Devices, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Specialized metabolites represent a prolific source of potential drug candidates. However, the process from detecting bioactivity in a crude metabolite extract to unambiguously identifying the active agent is a tedious and expensive endeavor. Speeding up this procedure is crucial, as new drugs, such as antibiotics, are urgently needed. Furthermore, the systematic functional assessment of complex metabolome samples represents a key bottleneck in nontargeted metabolomics, which once solved, holds the potential to fundamentally advance our systematic understanding of biology. To tackle this central bioanalytical challenge, we developed a compound-resolved bioactivity-based metabolomics workflow that combines nontargeted liquid chromatography tandem mass spectrometry (LC-MS/MS), high frequency fractionation on microfluidic devices and subsequent readout with luminescent bioreporter strains. Central for this workflow is a custom high-speed (∼1 Hz frequency) fractionation device that spots the mobile phase onto a microfluidic paper-analytical device (μPAD) in parallel to MS/MS data acquisition. Subsequently, the μPAD can be overlaid with a bioreporter strain, which displays cellular stress by expressing luciferase. The luminescence signal can then be correlated to MS signals through their chromatographic profiles. We evaluated five different luciferase-expressing bioreporter strains which provide information about different antibacterial modes of action, and tested the workflow with different antibiotic standards and mixtures thereof, as well as crude extracts from the known antibiotic producer Saccharopolyspora erythraea. Our results demonstrated high sensitivity (up to 1 ng/spot, depending on compound and bioreporter) and the rapid identification of multiple antimicrobial compounds out of crude extracts, highlighting the practicality and high-throughput capability of this compound-resolved bioactivity-based metabolomics approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine (IMIT), University of Tübingen, 72076 Tübingen, Germany.
- Cluster of Excellence Controlling Microbes to Fight Infections (CMFI), University of Tübingen, 72076 Tübingen, Germany.
- German Center for Infection Research (DZIF), Partner Site Tübingen, 72076 Tübingen, Germany.
- Department of Microbiome Science, Max Planck Institute for Biology, 72076 Tübingen, Germany.
- University of Innsbruck, 6020 Innsbruck, Austria.
- Pharmaceutical Institute, Department of Pharmaceutical Biology, University of Tübingen, 72076 Tübingen, Germany.
ORCID-Profile: Christian Geibel, Leonardo Boldt, Giovanni Andrea Vitale, Harald Gross, Heike Brötz-Oesterhelt, Daniel Petras
Förderung
- NIGMS NIH HHS
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Deutsche Forschungsgemeinschaft
- Joint Genome Institute
- National Institute of General Medical Sciences
- Simons Foundation
Zitieren
APA
Geibel, C., Schubert, J., Knoblauch, S. B., Hernandez, A., Boldt, L., Schneider, D. C., Papadopoulos Lambidis, S., Vitale, G. A., Fleischer, J., Haussmann, M., Gross, H., Wang, M., Brötz-Oesterhelt, H., & Petras, D. (2025). High-Frequency Microfluidic Fractionation for Compound-Resolved Bioactivity-Based Metabolomics. Analytical Chemistry, 97(43), 24093-24104. https://doi.org/10.1021/acs.analchem.5c04612
Vancouver
Geibel C, Schubert J, Knoblauch SB, Hernandez A, Boldt L, Schneider DC, et al. High-Frequency Microfluidic Fractionation for Compound-Resolved Bioactivity-Based Metabolomics. Analytical Chemistry. 2025;97(43):24093-24104. doi:10.1021/acs.analchem.5c04612
BibTeX
@article{Geibel2025,
author = {Geibel, Christian and Schubert, Julian and Knoblauch, Simon B and Hernandez, Albert and Boldt, Leonardo and Schneider, Dana C and Papadopoulos Lambidis, Stilianos and Vitale, Giovanni Andrea and Fleischer, Jakub and Haussmann, Manuela and Gross, Harald and Wang, Mingxun and Brötz-Oesterhelt, Heike and Petras, Daniel},
title = {High-Frequency Microfluidic Fractionation for Compound-Resolved Bioactivity-Based Metabolomics},
journal = {Analytical Chemistry},
year = {2025},
volume = {97},
number = {43},
pages = {24093--24104},
doi = {10.1021/acs.analchem.5c04612}
}
EUVIMED